Bayer AG
Bayer AG (BAYRY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Bayer AG (BAYRY), featuring income statements, balance sheets, and cash flow data.
Bayer AG (BAYRY) Income Statement & Financial Overview
Analyze Bayer AG’s BAYRY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $13.74B | $11.73B | $9.97B | $11.14B |
| Cost of Revenue | $5.63B | $5.72B | $5.09B | $4.99B |
| Gross Profit | $8.11B | $6.006B | $4.88B | $6.15B |
| Gross Profit Ratio | $0.59 | $0.51 | $0.49 | $0.55 |
| R&D Expenses | $1.46B | $1.73B | $1.56B | $1.50B |
| SG&A Expenses | $3.71B | $4.33B | $3.73B | $4.05B |
| Operating Expenses | $5.79B | $2.47B | $4.88B | $5.22B |
| Total Costs & Expenses | $11.41B | $8.20B | $9.97B | $10.21B |
| Interest Income | $92.00M | $138.00M | $150.00M | $95.00M |
| Interest Expense | $584.00M | $385.00M | $642.00M | $682.00M |
| Depreciation & Amortization | $1.17B | $1.77B | $4.76B | $1.14B |
| EBITDA | $3.59B | $1.67B | $1.06B | $1.76B |
| EBITDA Ratio | $0.26 | $0.14 | $0.11 | $0.16 |
| Operating Income | $2.32B | $3.53B | -$3.82B | $930.00M |
| Operating Income Ratio | $0.17 | $0.30 | -$0.38 | $0.08 |
| Other Income/Expenses (Net) | -$494.00M | -$4.01B | -$525.00M | -$1.03B |
| Income Before Tax | $1.83B | -$481.00M | -$4.35B | -$97.00M |
| Income Before Tax Ratio | $0.13 | -$0.04 | -$0.44 | -$0.009 |
| Income Tax Expense | $526.00M | -$153.00M | -$153.00M | -$71.00M |
| Net Income | $1.30B | -$335.00M | -$4.18B | -$34.00M |
| Net Income Ratio | $0.09 | -$0.03 | -$0.42 | -$0.003 |
| EPS | $1.32 | -$0.34 | -$4.26 | -$0.03 |
| Diluted EPS | $1.32 | -$0.34 | -$4.26 | -$0.03 |
| Weighted Avg Shares Outstanding | $982.42M | $982.42M | $982.42M | $982.42M |
| Weighted Avg Shares Outstanding (Diluted) | $982.42M | $982.42M | $982.42M | $982.42M |
Over the last four quarters, Bayer AG's revenue moved from $11.14B in Q2 2024 to $13.74B in Q1 2025. Operating income in Q1 2025 was $2.32B, with a strong operating margin of 17%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Bayer AG remained robust at $3.59B, reflecting operational efficiency. Net income rose to $1.30B, with an EPS of $1.32. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan